# Relmada Therapeutics, Inc.: Form 8-K, filed Feb 11, 2019

- Company: [Relmada Therapeutics, Inc.](/companies/rlmd.md) (CIK 1553643)
- Form: 8-K
- Filed: 2019-02-11
- Accepted by EDGAR: Feb 11, 2019, 08:00 ET
- Period: 2019-02-06
- Accession: 0001213900-19-002029
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1553643/000121390019002029/f8k020519_relmadatherap.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1553643/000121390019002029/

## Items reported

- Item 1.01: Entry into a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1553643/000121390019002029/f8k020519_relmadatherap.htm

Filed Feb 11, 2019.
Source: SEC EDGAR, the filing index for accession 0001213900-19-002029. Last ingested by Listed: Nov 13, 2026, 15:42 ET. No prices; not investment advice.
